Cigna Group $CI Shares Sold by Orion Porfolio Solutions LLC

Orion Porfolio Solutions LLC lowered its stake in Cigna Group (NYSE:CI) by 14.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,964 shares of the health services provider’s stock after selling 6,558 shares during the period. Orion Porfolio Solutions LLC’s holdings in Cigna Group were worth $11,231,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in CI. Massachusetts Financial Services Co. MA raised its stake in Cigna Group by 1.1% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after acquiring an additional 123,479 shares during the last quarter. Dodge & Cox raised its stake in shares of Cigna Group by 0.7% in the second quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock worth $2,958,893,000 after purchasing an additional 60,877 shares during the last quarter. Norges Bank acquired a new stake in shares of Cigna Group during the second quarter worth about $1,110,426,000. Arrowstreet Capital Limited Partnership boosted its position in Cigna Group by 24.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after buying an additional 492,045 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Cigna Group by 0.7% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock worth $678,652,000 after buying an additional 15,014 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.70% of the company’s stock.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna received an independent credit-rating vote of confidence: AM Best affirmed A (Excellent) FSR and “a+” long?term issuer credit ratings for Cigna’s core life/health subsidiaries — supports financial stability and capital strength. AM Best affirms ratings
• Positive Sentiment: Cigna formally named President & COO Brian Evanko as its next CEO (effective July 1) and said Cordani will move to executive chair; management also reaffirmed 2026 financial outlook — the internal succession and guidance reaffirmation reduce execution/guidance risk versus an outsider pick. Cigna appoints Brian Evanko
• Neutral Sentiment: Cigna executives appeared at the TD Cowen healthcare conference this week — useful for incremental detail and Q&A but not a market-moving catalyst on its own. TD Cowen presentation notice
• Neutral Sentiment: Broader health-care weakness intraday pressured peers as the NYSE Health Care Index slipped — sector moves amplify company-specific headlines but are not unique to CI. Sector update
• Negative Sentiment: Market reaction to the CEO transition has been negative in the near term — investors appear concerned about leadership change and potential strategic shifts at Evernorth/PBM despite the internal appointment. Seeking Alpha on leadership transition
• Negative Sentiment: Piper Sandler (per recent coverage) issued a cautious note on near?term outlook for CI, which can weigh on sentiment even if other analysts remain constructive. Piper Sandler pessimistic forecast
• Negative Sentiment: Insider selling was reported (director-level sale of ~1.7k shares) — small in isolation but often cited by traders as a short-term negative signal. Insider trade filing

Cigna Group Trading Down 1.2%

Shares of Cigna Group stock opened at $281.21 on Friday. The firm has a 50-day simple moving average of $280.80 and a two-hundred day simple moving average of $284.43. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a market cap of $74.11 billion, a P/E ratio of 12.68, a price-to-earnings-growth ratio of 0.99 and a beta of 0.27.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is currently 27.23%.

Analyst Upgrades and Downgrades

Several analysts have commented on CI shares. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research report on Tuesday, February 10th. Mizuho set a $325.00 price target on Cigna Group in a research report on Friday, January 9th. Zacks Research raised Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Finally, Robert W. Baird lowered their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $330.42.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.